Prognostic value of inflammatory markers in nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era
Cancer Management and Research Sep 03, 2021
Li Q, Yu L, Yang P, et al. - Through retrospectively analyzing data from nasopharyngeal carcinoma (NPC) patients from the Renmin Hospital of Wuhan University, the authors discovered that high neutrophil-to-lymphocyte ratio (NLR), platelet-lymphocyte-ratio (PLR), systemic immune index (SII), and systemic inflammation response index (SIRI) were significantly linked to poor overall survival (OS) and progression-free survival (PFS) in NPC patients. In the IMRT era, a high systemic inflammation response index (SIRI) may be an independent risk factor for PFS of NPC patients.
Between January 2012 and July 2020, 342 NPC patients were recruited.
The authors found optimal cut-off values of 2.65, 184.91, 804.08, and 1.34 for NLR, PLR, SII, and SIRI, respectively.
K-M survival analysis showed that high NLR, PLR, SII, and SIRI were significantly linked to worse OS and PFS relative to those in the low groups.
Results from univariate Cox analysis revealed that clinical, T, and M stages, as well as NLR, PLR, SII, and SIRI were correlated with OS, whereas age, alongside the aforementioned parameters, was related to PFS.
Furthermore, multivariate Cox analysis revealed that age ≥ 49 years and M1 stage were independent predictors of OS, whereas SIRI ≥ 1.34 and M1 stage were independent predictors of PFS.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries